(Q46909327)

26 December 2017

title

Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey (English)

1 reference

26 December 2017

0 references

0 references

1 reference

8

Jouko Lönnqvist

1 reference

26 December 2017

Jonna Perälä

2

Jonna Perälä

1 reference

26 December 2017

Jaana Suvisaari

1

Jaana Suvisaari

1 reference

26 December 2017

Seppo Koskinen

7

Seppo Koskinen

1 reference

26 December 2017

Matti Joukamaa

6

Matti Joukamaa

1 reference

26 December 2017

Sami Pirkola

5

Sami Pirkola

1 reference

26 December 2017

Antti Reunanen

9

Antti Reunanen

1 reference

26 December 2017

Tommi Härkänen

Tommi Härkänen

4

0 references

author name string

Samuli I Saarni

3

1 reference

26 December 2017

publication date

1 April 2008

1 reference

26 December 2017

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

26 December 2017

volume

258

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

129-136

1 reference

26 December 2017

Prevalence and correlates of diabetes in national schizophrenia samples.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00406-007-0762-Y

The increasing medical burden in bipolar disorder

21 January 2018

1 reference

12 December 2020

Diabetes mellitus in patients with schizophrenia in Taiwan

1 reference

12 December 2020

Diabetes mellitus in schizophrenic patients

1 reference

12 December 2020

FDA warns antipsychotic drugs may be risky for elderly

1 reference

12 December 2020

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications

1 reference

12 December 2020

Atypical antipsychotics and glucose dysregulation: a systematic review

1 reference

12 December 2020

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

1 reference

12 December 2020

Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders

1 reference

12 December 2020

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

12 December 2020

Schizophrenia, antipsychotics and diabetes: Genetic aspects.

1 reference

12 December 2020

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?

1 reference

12 December 2020

Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

1 reference

12 December 2020

Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs

1 reference

12 December 2020

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

1 reference

12 December 2020

Dietary patterns and the incidence of type 2 diabetes

1 reference

12 December 2020

Treatment of cardiac risk factors among patients with schizophrenia and diabetes.

1 reference

12 December 2020

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

1 reference

12 December 2020

The unhealthy lifestyle of people with schizophrenia

1 reference

12 December 2020

Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

1 reference

12 December 2020

Risk of diabetes in offspring of parents with non-insulin-dependent diabetes

1 reference

12 December 2020

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

12 December 2020

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

1 reference

12 December 2020

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

12 December 2020

Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review

1 reference

12 December 2020

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

1 reference

12 December 2020

Covariance adjustment of rates based on the multiple logistic regression model

1 reference

12 December 2020

Lifetime prevalence of psychotic and bipolar I disorders in a general population

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia

1 reference

12 December 2020

Handgrip strength and insulin levels: cross-sectional and prospective associations in the Normative Aging Study.

1 reference

12 December 2020

Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods.

1 reference

12 December 2020

Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey.

1 reference

12 December 2020

Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients

1 reference

12 December 2020

Type 2 diabetes mellitus, cognitive impairment and dementia.

1 reference

12 December 2020

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

1 reference

12 December 2020

Effects of smoking, obesity and physical activity on the risk of type 2 diabetes in middle-aged Finnish men and women

1 reference

12 December 2020

General-medical conditions in older patients with serious mental illness.

1 reference

12 December 2020

Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients

1 reference

12 December 2020

Type 2 diabetes: principles of pathogenesis and therapy

1 reference

12 December 2020

Data on diabetes from the French cohort study in schizophrenia

1 reference

12 December 2020

10.1007/S00406-007-0762-Y

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017